Sickle Cell Anemia Screening and Prevention in Northern Israel
Summary of the Data From the Prevention Programme for Hemoglobinopathies in Northern Israel
1 other identifier
observational
69
1 country
1
Brief Summary
Since 1987, a screening for β Thalassemia in pregnant women is carried on in northern Israel, and from 1999 all the samples were tested also for Hgb S, Hgb C, Hgb D, Hgb O Arab and others. In this study, the investigators intend to summarize the results of this preventive program aiming to detect couples at risk for having offspring with Thalassemia or SCA, the compliance regard to genetic counseling and prenatal diagnosis and the incidence of new affected babies born.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2008
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 14, 2008
CompletedFirst Posted
Study publicly available on registry
August 15, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2009
CompletedSeptember 1, 2015
August 1, 2015
10 months
August 14, 2008
August 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of carriers detected
End of study
Secondary Outcomes (1)
Couples referred for prenatal diagnosis
End of study
Study Arms (2)
A
Thalassemia Minor carriers
B
Sickle cell carriers
Interventions
Eligibility Criteria
The program for prevention of hemoglobinopathies in Northern Israel, instituted since 1987, covered the northern part of Israel, including the Jezreel valley, the Nazareth area, the upper Galilee, the Hula valley and the northern part of the seashore region7. The overall population in this region is about a million inhabitants with about 50 % of Arab population, and a significant percentage of them from Bedouin origin, a population that at least partially is of African origin.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- HaEmek Medical Center, Israellead
- Ministry of Health, Israelcollaborator
Study Sites (1)
Pediatric Hematology Unit - Ha'Emek Medical Center
Afula, Afula, 18101, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ariel Koren, MD
Pediatric Hematology Unit - Ha'Emek Medical Center - Afula - 18101 - Israel
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Pediatric Hematology Unit and Pediatric Dpt B
Study Record Dates
First Submitted
August 14, 2008
First Posted
August 15, 2008
Study Start
May 1, 2008
Primary Completion
March 1, 2009
Study Completion
March 1, 2009
Last Updated
September 1, 2015
Record last verified: 2015-08